CA2097060A1 - Anticorps bifonctionnels et leur methode de preparation - Google Patents

Anticorps bifonctionnels et leur methode de preparation

Info

Publication number
CA2097060A1
CA2097060A1 CA 2097060 CA2097060A CA2097060A1 CA 2097060 A1 CA2097060 A1 CA 2097060A1 CA 2097060 CA2097060 CA 2097060 CA 2097060 A CA2097060 A CA 2097060A CA 2097060 A1 CA2097060 A1 CA 2097060A1
Authority
CA
Canada
Prior art keywords
fab
antibody
binding
sequence
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2097060
Other languages
English (en)
Inventor
Peter J. Curtis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wistar Institute of Anatomy and Biology
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2097060A1 publication Critical patent/CA2097060A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA 2097060 1990-12-04 1991-12-03 Anticorps bifonctionnels et leur methode de preparation Abandoned CA2097060A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62298390A 1990-12-04 1990-12-04
US07/622,983 1990-12-04

Publications (1)

Publication Number Publication Date
CA2097060A1 true CA2097060A1 (fr) 1992-06-05

Family

ID=24496305

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2097060 Abandoned CA2097060A1 (fr) 1990-12-04 1991-12-03 Anticorps bifonctionnels et leur methode de preparation

Country Status (3)

Country Link
EP (1) EP0563214A4 (fr)
CA (1) CA2097060A1 (fr)
WO (1) WO1992010209A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5582996A (en) * 1990-12-04 1996-12-10 The Wistar Institute Of Anatomy & Biology Bifunctional antibodies and method of preparing same
EP0861893A3 (fr) * 1991-09-19 1999-11-10 Genentech, Inc. Expression de haut niveau d'immunoglobulines
US5932448A (en) * 1991-11-29 1999-08-03 Protein Design Labs., Inc. Bispecific antibody heterodimers
US5693322A (en) * 1993-03-11 1997-12-02 The United States Of America As Represented By The Department Of Health And Human Services Enhanced intercellular interaction by associational antibody molecules
EP0787185A2 (fr) 1994-10-20 1997-08-06 MorphoSys AG Hetero-association ciblee de proteines recombinees et de complexes fonctionnels
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
ES2246069T3 (es) 1997-05-02 2006-02-01 Genentech, Inc. Procedimiento de preparacion de anticuerpos multiespecificos que tienen componentes comunes y multimericos.
US7951917B1 (en) 1997-05-02 2011-05-31 Genentech, Inc. Method for making multispecific antibodies having heteromultimeric and common components
US20020062010A1 (en) 1997-05-02 2002-05-23 Genentech, Inc. Method for making multispecific antibodies having heteromultimeric and common components
RU2316337C2 (ru) 2001-04-24 2008-02-10 Мерк Патент Гмбх КОМБИНИРОВАННАЯ ТЕРАПИЯ, ИСПОЛЬЗУЮЩАЯ АНТИАНГИОГЕННЫЕ СРЕДСТВА И TNF-α
AU2016244273B2 (en) * 2003-05-06 2018-10-18 Bioverativ Therapeutics Inc. Immunoglobulin Chimeric Monomer-Dimer Hybrids
TWI353991B (en) * 2003-05-06 2011-12-11 Syntonix Pharmaceuticals Inc Immunoglobulin chimeric monomer-dimer hybrids
US7348004B2 (en) 2003-05-06 2008-03-25 Syntonix Pharmaceuticals, Inc. Immunoglobulin chimeric monomer-dimer hybrids
DE602004031390D1 (de) 2003-05-06 2011-03-24 Syntonix Pharmaceuticals Inc Gerinnungsfaktor VII-Fc chimäre Proteine zur Behandlung von hämostatischen Krankheiten
EP1973569B1 (fr) 2006-01-18 2013-05-22 Merck Patent GmbH Traitement specifique utilisant des ligands de integrine destine a traiter un cancer
WO2008027236A2 (fr) 2006-08-30 2008-03-06 Genentech, Inc. Anticorps multispécifiques
PL2101805T3 (pl) 2007-01-18 2013-04-30 Merck Patent Gmbh Ligandy integryn do stosowania w leczeniu nowotworów
AU2009288167B2 (en) 2008-09-03 2015-10-22 Genentech, Inc. Multispecific antibodies
WO2010136168A2 (fr) 2009-05-25 2010-12-02 Merck Patent Gmbh Administration continue de ligands d'intégrines pour le traitement du cancer
TWI586806B (zh) 2010-04-23 2017-06-11 建南德克公司 異多聚體蛋白質之製造
CN103153328A (zh) 2010-07-16 2013-06-12 默克专利股份有限公司 肽在乳腺癌和/或骨转移灶的治疗中的用途
BR112016024462B1 (pt) 2014-05-06 2022-12-27 Genentech, Inc Métodos para a preparação de um anticorpo
TW202016151A (zh) 2018-06-09 2020-05-01 德商百靈佳殷格翰國際股份有限公司 針對癌症治療之多特異性結合蛋白

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL89491A0 (en) * 1988-11-17 1989-09-10 Hybritech Inc Bifunctional chimeric antibodies
DE3920358A1 (de) * 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
US5932448A (en) * 1991-11-29 1999-08-03 Protein Design Labs., Inc. Bispecific antibody heterodimers

Also Published As

Publication number Publication date
EP0563214A4 (en) 1994-08-17
EP0563214A1 (fr) 1993-10-06
WO1992010209A1 (fr) 1992-06-25

Similar Documents

Publication Publication Date Title
US5582996A (en) Bifunctional antibodies and method of preparing same
CA2097060A1 (fr) Anticorps bifonctionnels et leur methode de preparation
US11466085B2 (en) Anti-PD-L1 nanobody, coding sequence and use thereof
US5489516A (en) Hybridoma and monoclonal antibody specific for human stem cell factor receptor and methods of use of the monoclonal antibody for detection of stem cell factor receptors
US6623940B1 (en) Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
JP3105898B2 (ja) 組換えｄｎａタンパクの製造方法
CA2035899C (fr) Anticorps anti-antigene carcino-embryonnaire chimerique
RU2204606C2 (ru) Антитело vff-18 и его аналоги
JP2935520B2 (ja) ガン治療に用いられる新規高親和性改変抗体系統群
JP2005538682A (ja) カルボキシックアンヒドラーゼｉｘ（ｃａｉｘ）腫瘍抗原に対する抗体
US20070199078A1 (en) Antibody fragments specific for human carcinoembryonic antigen (CEA)
EP0457875A1 (fr) Anticorps a10 chimerique souris-humain avec specificite envers un antigene de cellule tumorale humaine
JPH09509043A (ja) 植物ブリオニア・ディオイカから単離された新規なリボソーム不活性化タンパク質
EP0203403B1 (fr) Cellule T clonée capable de reconnaître des tumeurs et un récepteur antigénique de cellule T
CA2019323A1 (fr) Anticorps km10 chimeriques humain - murin specifiques contre un antigene de cellules tumorales humaines
WO1991010722A2 (fr) Immunoglobuline chimerique pour recepteurs de cd4
JP2004507205A (ja) Ｃａ１９−９抗原陽性細胞の検出および除去のためのポリペプチド
CN114685670A (zh) Cldn18.2抗体及其应用
CN113321730B (zh) Cldn18.2抗体及其应用
WO2023125975A1 (fr) Construction et utilisation d'un nouveau lymphocyte t modifié par un récepteur antigénique chimérique ciblant flt3 humain
US7037496B2 (en) Chimeric immunoglobulin for CD4 receptors
US20070031409A1 (en) Recombinant DNA-molecule complex for the expression of anti-human-interferon-gamma chimeric antibodies or antibody fragments
JPH04187096A (ja) 二重特異性を有するハイブリッド・モノクローナル抗体
NO316023B1 (no) Fremgangsmåte for fremstilling av et terapeutisk aktivt antistoff eller etterapeutisk aktivt fragment derav som er selektive for TAG-72

Legal Events

Date Code Title Description
FZDE Dead